Literature DB >> 29044406

Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages.

Seong-Woo Kim1, Bindu Subhadra1, Jake Whang1, Yong Woo Back1, Hyun Shik Bae1, Hwa-Jung Kim1, Chul Hee Choi1.   

Abstract

Autophagy is known to be a vital homeostatic defense process that controls mycobacterial infection. However, the relationship between autophagy response and the virulence of Mycobacterium abscessus strain UC22 has not been reported. Here, we demonstrate that M. abscessus induces autophagy and inhibits autophagy flux in murine macrophages. Further, the rough variant of M. abscessus, UC22 that is a highly virulent clinical isolate, significantly inhibited autophagic flux than the smooth variant of M. abscessus ATCC 19977. In addition, it was noticed that the intracellular survival of UC22 is significantly enhanced by blocking the autophagosome-lysosome fusion in macrophages compared to the smooth variant. However, Mycobacterium smegmatis did not block autophagy flux in murine macrophages. Besides, we confirmed that the lipid components of M. abscessus UC22 play a role in autophagosome formation. These data suggest that the virulent M. abscessus might be able to survive and grow within autophagosomes by preventing the autophagosome-lysosome fusion and their clearance from the cells. © FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Mycobacterium abscessus; autophagy; intracellular survival; lipid; virulence

Mesh:

Substances:

Year:  2017        PMID: 29044406     DOI: 10.1093/femspd/ftx107

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  8 in total

1.  Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy.

Authors:  Kerstin Pohl; Xue A Grimm; Silvia M Caceres; Katie R Poch; Noel Rysavy; Milene Saavedra; Jerry A Nick; Kenneth C Malcolm
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

Review 2.  Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.

Authors:  Javeed A Shah; Cecilia S Lindestam Arlehamn; David J Horne; Alessandro Sette; Thomas R Hawn
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

Review 3.  NTM drug discovery: status, gaps and the way forward.

Authors:  Mu-Lu Wu; Dinah B Aziz; Véronique Dartois; Thomas Dick
Journal:  Drug Discov Today       Date:  2018-04-07       Impact factor: 7.851

Review 4.  Pulmonary non-tuberculous mycobacterial infections: current state and future management.

Authors:  Kai Ling Chin; Maria E Sarmiento; Nadine Alvarez-Cabrera; Mohd Nor Norazmi; Armando Acosta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-18       Impact factor: 3.267

Review 5.  Targeting Autophagy as a Strategy for Developing New Vaccines and Host-Directed Therapeutics Against Mycobacteria.

Authors:  Emily J Strong; Sunhee Lee
Journal:  Front Microbiol       Date:  2021-01-14       Impact factor: 6.064

Review 6.  Host-Pathogen Interactions Operative during Mycobacteroides abscessus Infection.

Authors:  Eun-Jin Park; Prashanta Silwal; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2021-12-23       Impact factor: 6.303

Review 7.  Autophagy and Host Defense in Nontuberculous Mycobacterial Infection.

Authors:  Prashanta Silwal; In Soo Kim; Eun-Kyeong Jo
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561

Review 8.  Out-Smarting the Host: Bacteria Maneuvering the Immune Response to Favor Their Survival.

Authors:  Nastaran Mues; Hong Wei Chu
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.